Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) EBIT Margin (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed EBIT Margin for 3 consecutive years, with 36.63% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT Margin rose 1057.0% year-over-year to 36.63%, compared with a TTM value of 33.26% through Sep 2025, down 3926.0%, and an annual FY2024 reading of 34.23%, down 228.0% over the prior year.
  • EBIT Margin was 36.63% for Q3 2025 at SBC Medical Group Holdings, up from 33.57% in the prior quarter.
  • Across five years, EBIT Margin topped out at 11491.98% in Q4 2023 and bottomed at 10.62% in Q4 2024.
  • Average EBIT Margin over 3 years is 1309.82%, with a median of 42.35% recorded in 2023.
  • The sharpest move saw EBIT Margin crashed -1148136bps in 2024, then skyrocketed 1057bps in 2025.
  • Year by year, EBIT Margin stood at 11491.98% in 2023, then plummeted by -100bps to 10.62% in 2024, then soared by 245bps to 36.63% in 2025.
  • Business Quant data shows EBIT Margin for SBC at 36.63% in Q3 2025, 33.57% in Q2 2025, and 51.14% in Q1 2025.